Dopaminergic Mechanisms of Reduced Basal Ganglia Responses to Hedonic Reward During Interferon Alfa Administration
Open accessAbstract
CONTEXT: Inflammatory cytokines or cytokine inducers can alter basal ganglia activity, including reducing responsiveness to rewarding stimuli that may be mediated by cytokine effects on dopamine function. OBJECTIVES: To determine whether long-term administration of the inflammatory cytokine interferon alfa reduces the basal ganglia response to reward and whether such changes are associated with decreased presynaptic striatal dopamine function and altered behavior. DESIGN: Cross-sectional and longitudinal studies. SETTING: Outpatient research unit and neuroimaging facilities at Emory University, Atlanta, Georgia. PATIENTS: Medically stable adults with chronic hepatitis C virus (HCV) infection eligible for interferon alfa treatment. MAIN OUTCOME MEASURES: Neural activity in the ventral striatum during a hedonic reward task as measured by functional magnetic resonance imaging, uptake and turnover of radiolabeled fluorodopa F 18 (18F-dopa) in caudate and putamen using positron emission tomography, and interferon alfa-induced depression, anhedonia, fatigue, and neurotoxicity. RESULTS: Patients with HCV receiving interferon alfa for 4 to 6 weeks (n = 14) exhibited significantly reduced bilateral activation of the ventral striatum in the win vs lose condition of a gambling task compared with patients with HCV awaiting interferon alfa treatment (n = 14). Reduced activation of the ventral striatum was, in turn, significantly correlated with anhedonia, depression, and fatigue. In a separate longitudinal study, patients with HCV treated with interferon alfa for 4 to 6 weeks (n = 12) exhibited significantly increased 18F-dopa uptake and decreased 18F-dopa turnover in caudate and putamen and in the same ventral striatal regions identified in the functional magnetic resonance imaging study. Baseline and percentage change in 18F-dopa uptake and turnover were correlated with behavioral alterations, including depression, fatigue, and neurotoxicity, during interferon alfa administration. CONCLUSIONS: These data replicate and extend findings that inflammatory stimuli, including inflammatory cytokines, such as interferon alfa, alter basal ganglia activity and behavior in association with significant changes in presynaptic striatal dopamine function consistent with decreased dopamine synthesis or release.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Reduced activation of the ventral striatum is significantly correlated with greater symptoms of anhedonia, depression, and fatigue.
“Reduced activation of the ventral striatum, in turn, was significantly correlated with greater symptoms of anhedonia, depression, and fatigue”
From From stress to inflammation and major depressive disorder: A social signal transduction theory of depression. (2014) · cites this paper as Capuron et al., 2012
The Results section (page not provided) reports that lower ventral-striatal activity was associated with greater neuropsychiatric symptoms, with the strongest correlations for reduced motivation, reduced activity, and depression. It also reports greater anhedonia in the interferon-treated group, but the Results passage does not establish a significant correlation between ventral-striatal activity and anhedonia specifically. (LLM, conf=0.78)
Experimental — accuracy not yet measuredCapuron and colleagues found decreased blood-oxygen level dependent responses in the ventral striatal regions during a hedonic gambling reward task in patients with HCV treated with IFN-α.
“Similarly, Capuron and colleagues examined PET changes in patients with HCV treated with IFN-α and found decreased blood-oxygen level dependent responses in the ventral striatal regions during a hedonic gambling reward task.”
From Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories (2023) · cites this paper as [140]
The Results section reports reduced ventral-striatal responses during winning versus losing trials in interferon alfa–treated patients with HCV. However, the Methods identify those blood-oxygen-level-dependent measurements as fMRI findings; the separate PET study measured dopamine uptake and turnover, not gambling-task responses. (LLM, conf=0.86)
Experimental — accuracy not yet measuredReduced activity in the ventral striatum was interrelated with reduced motivation, fatigue, and depressed mood on the neurotoxicity scale.
“Reduced activity in the ventral striatum was interrelated with reduced motivation, fatigue, and depressed mood on the neurotoxicity scale (140).”
From Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories (2023) · cites this paper as [140]
The Results section reports that reduced ventral striatal activity was associated with greater neuropsychiatric symptoms, particularly reduced motivation and depression; the Abstract also reports correlations with fatigue. But the Methods section identifies motivation as a Multidimensional Fatigue Inventory measure and depression as a Montgomery-Asberg Depression Rating Scale measure, not measures on the Neurotoxicity Rating Scale. No page numbers are available in our copy. (LLM, conf=0.88)
Experimental — accuracy not yet measuredCytokines decrease dopamine release in the basal ganglia, associated with decreased effort-based motivation and reduced activation of reward circuitry in the ventral striatum.
“Dopamine has a fundamental role in motivation and motor activity, and cytokines have been shown to decrease the release of dopamine in the basal ganglia in association with decreased effort-based motivation as well as reduced activation of reward circuitry in the basal ganglia, in particular the ventral striatum89–91.”
From The role of inflammation in depression: from evolutionary imperative to modern treatment target (2016) · cites this paper as [89]
The Comment section reports reduced ventral-striatal responses to reward and altered dopamine function during interferon alfa treatment. The Conclusions describe the dopamine findings as consistent with decreased synthesis or release, not a direct demonstration of decreased release. The paper links these changes to anhedonia and fatigue, but does not establish decreased effort-based motivation. (LLM, conf=0.87)
Experimental — accuracy not yet measuredInflammatory stimuli are associated with reductions in reward responsiveness in the striatum across multiple neuroimaging platforms in otherwise non-depressed individuals given IFNα, endotoxin or typhoid vaccination.
“Inflammatory stimuli have been associated with reductions in reward responsiveness in the striatum across many neuroimaging platforms, demonstrating the validity and reproducibility of these cytokine-mediated effects on the brain in otherwise non-depressed individuals peripherally administered IFNα, endotoxin or typhoid vaccination and imaged by PET, functional magnetic resonance imaging (fMRI), M”
From The role of inflammation in depression: from evolutionary imperative to modern treatment target (2016) · cites this paper as [89]
The Results report reduced ventral-striatal responses to reward during IFNα treatment, and the background discussion reports a similar reward-related reduction after endotoxin. But its account of typhoid vaccination describes increased substantia nigra reactivity during visual stimulation, not reduced striatal reward responsiveness. The Methods exclude recent major depression at enrollment, while the Results report depressive symptoms during IFNα treatment, so “otherwise non-depressed” needs that qualification. Page numbers are unavailable in our copy. (LLM, conf=0.87)
Experimental — accuracy not yet measured
Long-term administration of IFNα is associated with reduced neural responses to a hedonic reward task in the bilateral ventral striatum.
“long-term administration of IFNα is associated with reduced neural responses to a hedonic reward task in the bilateral ventral striatum”
From From stress to inflammation and major depressive disorder: A social signal transduction theory of depression. (2014) · cites this paper as Capuron et al., 2012
In hepatitis C patients receiving IFN-α for 4-6 weeks, PET with 18F-dopa showed increased uptake and decreased turnover of 18F-dopa in the same ventral striatal regions affected by IFN-α in the fMRI study.
“Patients exhibited increased uptake and decreased turnover of 18F-dopa in the same ventral striatal regions shown to be effected by IFN-α in the previously mentioned fMRI study (Capuron et al., 2012).”
From The role of inflammation in core features of depression: Insights from paradigms using exogenously-induced inflammation. (2018) · cites this paper as Capuron et al., 2012
Reduced ventral striatal activation was significantly associated with more severe symptoms of anhedonia, depressed mood, and fatigue.
“Reduced ventral striatal activation was in turn significantly associated with more severe symptoms of anhedonia, depressed mood, and fatigue (Capuron et al., 2012).”
From The role of inflammation in core features of depression: Insights from paradigms using exogenously-induced inflammation. (2018) · cites this paper as Capuron et al., 2012
These changes may occur through proinflammatory cytokine effects on dopaminergic functioning in the ventral striatum.
“These changes may occur through the effect of proinflammatory cytokines on dopaminergic functioning in the ventral striatum (Capuron et al., 2012), as outlined in section 1.2.”
From The role of inflammation in core features of depression: Insights from paradigms using exogenously-induced inflammation. (2018) · cites this paper as Capuron et al., 2012
After 4-6 weeks of IFN-α therapy, hepatitis C patients showed significantly attenuated ventral striatal activity to receipt of monetary rewards in a gambling task compared with hepatitis C patients not receiving IFN-α.
“For example, after 4–6 weeks of IFN-α therapy, patients with hepatitis C showed significantly attenuated ventral striatal activity (as measured by fMRI) to receipt of monetary rewards in a gambling task when compared with hepatitis C patients not receiving IFN-α (Capuron et al., 2012).”
From The role of inflammation in core features of depression: Insights from paradigms using exogenously-induced inflammation. (2018) · cites this paper as Capuron et al., 2012
Baseline and percent change in FDOPA uptake and turnover correlated with IFN-alpha-induced depression and fatigue scores.
“Baseline and percent change in FDOPA uptake and turnover were, in turn, correlated with IFN-alpha-induced depression and fatigue scores.”
From Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications (2013) · cites this paper as Capuron et al., 2012
In IFN-alpha-treated HCV+ subjects, FDOPA PET showed increased uptake and decreased turnover in the caudate, putamen, and ventral striatum.
“Interestingly, both increased uptake and decreased turnover of FDOPA in the caudate, putamen and ventral striatum of IFN-alpha-treated patients was found (Capuron et al., 2012).”
From Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications (2013) · cites this paper as Capuron et al., 2012
fMRI demonstrated decreased neural activation to a hedonic reward task during IFN-alpha administration that correlated with reduced motivation.
“Functional magnetic resonance imaging (fMRI) has also demonstrated decreased neural activation to a hedonic reward task during IFN-alpha administration that correlated with reduced motivation (Capuron et al., 2012).”
From Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications (2013) · cites this paper as Capuron et al., 2012
Pro-inflammatory cytokines can affect the release of neurotransmitters.
“Moreover, pro-inflammatory cytokines can affect the release of neurotransmitters (93).”
From Cytokine Research in Depression: Principles, Challenges, and Open Questions (2019) · cites this paper as [93]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 57 · Cited by 382
- Authors
- Capuron, L., Pagnoni, G., Drake, D. F., Woolwine, B. J., Spivey, J. R., Crowe, R. J., Votaw, J. R., Goodman, M. M., & Miller, A. H.
- Affiliations
- Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement (FR)
- University of Modena and Reggio Emilia (IT)
- ORCID
- Venue
- Archives of General Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 2012-10-01
- Volume
- 69
- Issue
- 10
- Pages
- 1044
- ISSN
- 0003-990X (ISSN-L)
- PMC
- PMC3640298
- OpenAlex
- W2060913403
- Cited by
- 382
- References
- 57
- Citations by year
- 2026: 16 · 2025: 28 · 2024: 27 · 2023: 25 · 2022: 30 · 2021: 29 · 2020: 39 · 2019: 35 · 2018: 31 · 2017: 33 · 2016: 37 · 2015: 22 · 2014: 13 · 2013: 13 · 2012: 3
- FWCI
- 5.02
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Archives of General Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- HAL (submittedVersion)
- IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by)
- Oskar-Bordeaux (Universite de Bordeaux) (submittedVersion)
- Funders
- Dana Foundation
- National Institutes of Health (M01-RR0039, UL1TR000454, RR0039, RR025008)
- National Institute of Mental Health (MH 067990, R01MH083746, R01MH067990, R01MH087604, R01MH060723)
- National Cancer Institute (P30CA138292)
- National Center for Research Resources (UL1RR025008, RR025008, M01RR000039, M01-RR-0039)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Keywords
- interferon-alpha, basal ganglia, ventral striatum, hedonic reward, dopaminergic activity, striatal dopamine synthesis, 18F-DOPA PET, caudate nucleus, putamen, hepatitis C, anhedonia, depression, fatigue, inflammatory cytokines, gambling task
- MeSH terms
- Adult, Mental Disorders, Corpus Striatum, Dihydroxyphenylalanine, Dopamine, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Neuropsychological Tests, Reward, Interferon-alpha, Hepatitis C, Chronic, Positron-Emission Tomography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review